These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 34506684)

  • 1. Coronavirus Disease 2019 Messenger RNA Vaccine and Liver Transplant Recipients.
    Mungmunpuntipantip R; Wiwanitkit V
    Liver Transpl; 2022 Jan; 28(1):140. PubMed ID: 34506684
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients.
    Cholankeril G; Al-Hillan A; Tarlow B; Abrams D; Jacobs JS; Flores NP; Rana A; Kanwal F; Goss JA
    Liver Transpl; 2022 Jan; 28(1):123-126. PubMed ID: 34724328
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
    Davidov Y; Tsaraf K; Cohen-Ezra O; Likhter M; Ben Yakov G; Levy I; Levin EG; Lustig Y; Mor O; Rahav G; Ben Ari Z
    Liver Transpl; 2022 Feb; 28(2):215-223. PubMed ID: 34767690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
    Transpl Int; 2021; 35():10026. PubMed ID: 35185359
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients.
    Guarino M; Esposito I; Portella G; Cossiga V; Loperto I; Tortora R; Cennamo M; Capasso M; Terracciano D; Galeota Lanza A; Di Somma S; Picciotto FP; Morisco F;
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1534-1541.e4. PubMed ID: 35066136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.
    Reischig T; Kacer M; Vlas T; Drenko P; Kielberger L; Machova J; Topolcan O; Kucera R; Kormunda S
    Am J Transplant; 2022 Mar; 22(3):801-812. PubMed ID: 34860470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Masset C; Benotmane I; Dantal J; Garandeau C; Gauthier-Vargas G; Cantarovich D; Meurette A; Giral M; Caillard S; Blancho G
    Kidney Int; 2022 Apr; 101(4):825-826. PubMed ID: 35167873
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.
    Hirama T; Akiba M; Shundo Y; Watanabe T; Watanabe Y; Oishi H; Niikawa H; Okada Y
    J Infect Chemother; 2022 Aug; 28(8):1153-1158. PubMed ID: 35599079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.
    Toniutto P; Aghemo A; Grossi P; Burra P;
    Dig Liver Dis; 2021 Oct; 53(10):1232-1234. PubMed ID: 34393073
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
    Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
    Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
    Dumortier J
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101743. PubMed ID: 34146727
    [No Abstract]   [Full Text] [Related]  

  • 12. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients.
    Odriozola A; Lamadrid-Perojo P; Cuadrado A; San Segundo D; Del Barrio M; Fortea JI; Puente A; Amigo L; Fernández-Santiago R; Castillo F; Achalandabaso M; Andrés Echeverri J; Rodríguez-Sanjuan JC; López-Hoyos M; Crespo J; Fábrega E
    Transplantation; 2022 Jul; 106(7):e341-e342. PubMed ID: 35323163
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
    Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; McAteer J; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Mogul DB
    Am J Transplant; 2022 Oct; 22(10):2481-2483. PubMed ID: 35510786
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    Mazuecos A; Villanego F; Zarraga S; López V; Oppenheimer F; Llinàs-Mallol L; Hernández AM; Rivas A; Ruiz-Fuentes MC; Toapanta NG; Jiménez C; Cabello S; Beneyto I; Aladrén MJ; Rodríguez-Benot A; Canal C; Molina M; Pérez-Flores I; Saura IM; Gavela E; Franco A; Lorenzo I; Galeano C; Tabernero G; Pérez-Tamajón L; Martín-Moreno PL; Fernández-Girón F; Siverio O; Labrador PJ; De Arriba G; Simal F; Cruzado L; Moina I; Alcalde G; Sánchez-Álvarez E; Pascual J; Crespo M;
    Transplantation; 2022 Jul; 106(7):1430-1439. PubMed ID: 35384924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.
    Zecca E; Rizzi M; Tonello S; Matino E; Costanzo M; Rizzi E; Casciaro GF; Manfredi GF; Acquaviva A; Gagliardi I; Calzaducca E; Mallela VR; D'Onghia D; Minisini R; Bellan M; Castello LM; Gavelli F; Avanzi GC; Patrucco F; Chiocchetti A; Pirisi M; Rigamonti C; Lilleri D; Sola D; Sainaghi PP
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
    Charmetant X; Espi M; Benotmane I; Barateau V; Heibel F; Buron F; Gautier-Vargas G; Delafosse M; Perrin P; Koenig A; Cognard N; Levi C; Gallais F; Manière L; Rossolillo P; Soulier E; Pierre F; Ovize A; Morelon E; Defrance T; Fafi-Kremer S; Caillard S; Thaunat O
    Sci Transl Med; 2022 Mar; 14(636):eabl6141. PubMed ID: 35103481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
    Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
    J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
    Hoffman TW; Meek B; Rijkers GT; van Kessel DA
    Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.